Drugs / Comp04
last change Sep 2014 re-read 3 minutes ago

Comp04

Developed for
actinic keratosis
Investigated by
Promius Pharma, LLC

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02126670 Apr → Sep 2014 actinic keratosis Promius Pharma, LLC Completed Missed primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Comp04 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02126670 ↗